SCHEMBL23837549

SCHEMBL23837549

CCCCOC(=O)c1cccc2c1CBC(NC(=O)CCc1cncs1)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 2/20 0.41
▸ TSHR P16473 4/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ TDP1 Q9NUW8 3/20 0.36
▸ ALDH1A1 P00352 5/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MTNR1A P48039 1/20 0.32
▸ MTNR1B P49286 1/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ ADRA1B P35368 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23837455 0.79 TRPA1 (0.42) TRPA1TSHRL3MBTL1TDP1ALDH1A1
SCHEMBL17347741 0.78 TRPA1 (0.37) TRPA1TSHRL3MBTL1TDP1ALDH1A1
SCHEMBL17337031 0.78 TRPA1 (0.37) TRPA1TSHRL3MBTL1TDP1ALDH1A1
SCHEMBL23837397 0.78 MTNR1A (0.30) MTNR1AMTNR1B
SCHEMBL23837600 0.71 TBXAS1 (0.39) TSHRTDP1ALDH1A1HSD17B10TP53
SCHEMBL23837590 0.70 ALDH1A1 (0.39) TRPA1TSHRL3MBTL1TDP1ALDH1A1
SCHEMBL23837548 0.70 — —
SCHEMBL23837423 0.70 TRPA1 (0.37) TRPA1TSHRL3MBTL1TDP1ALDH1A1
SCHEMBL17337619 0.70 TSHR (0.35) TSHRSMN1; SMN2NPC1MAPTRAB9A
SCHEMBL17337616 0.70 TSHR (0.35) TSHRSMN1; SMN2NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback